AMN Healthcare
275 hedge funds and large institutions have $2.62B invested in AMN Healthcare in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 98 increasing their positions, 109 reducing their positions, and 55 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
31% more call options, than puts
Call options by funds: $18.6M | Put options by funds: $14.2M
23% more capital invested
Capital invested by funds: $2.14B → $2.62B (+$488M)
4.81% less ownership
Funds ownership: 100.52% → 95.72% (-4.8%)
7% less funds holding
Funds holding: 297 → 275 (-22)
10% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 109
36% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 55
Top Buyers
Top Sellers
AMN Hedge Fund Activity: Q3 2020 in Review
275 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AMN Healthcare (AMN) for Q3 2020, worth a combined $2.62B — up 23% from $2.14B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of AMN and 35 opened new positions — a net loss of 20 holders — while 109 trimmed existing stakes and 98 added.
The largest buyer was Riverbridge Partners, adding an estimated $29.6M. The largest seller was Kayne Anderson Rudnick Investment Management, cutting an estimated $50.3M.
- 275 institutional investors held AMN Healthcare (AMN) as of Q3 2020, down from 297 in Q2 2020.
- Funds reported $2.62B of AMN Healthcare stock for Q3 2020, up 23% quarter-over-quarter.
- 35 funds opened new AMN Healthcare positions in Q3 2020 and 55 closed out, a net change of -20 holders.
- The largest AMN Healthcare buyer in Q3 2020 was Riverbridge Partners, an estimated $29.6M added.
- The largest AMN Healthcare seller in Q3 2020 was Kayne Anderson Rudnick Investment Management, an estimated $50.3M sold.
Based on aggregated 13F filings for Q3 2020.